170
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Fever, Wide Distribution of Viral Pneumonia, and Pleural Effusion are More Critical Findings at the First Visit in Predicting the Prognosis of COVID-19: A Single Center, retrospective, Propensity Score-Matched Case–Control Study

ORCID Icon, , , , ORCID Icon, ORCID Icon, , & show all
Pages 2337-2348 | Received 16 Feb 2023, Accepted 18 May 2023, Published online: 08 Jun 2023

References

  • Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–758. doi:10.1136/postgradmedj-2020-138234
  • Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi:10.1001/jama.2020.12839
  • Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020;14(2):126–135. doi:10.1007/s11684-020-0767-8
  • Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020;30(8):4381–4389. doi:10.1007/s00330-020-06801-0
  • Li M, Lei P, Zeng B, et al. Coronavirus disease (COVID-19): spectrum of CT findings and temporal progression of the disease. Acad Radiol. 2020;27(5):603–608. doi:10.1016/j.acra.2020.03.003
  • Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):715–721. doi:10.1148/radiol.2020200370
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
  • Pranata R, Lim M, Yonas E, et al. Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis. Diabetes Metab. 2021;47(2):101178. doi:10.1016/j.diabet.2020.07.005
  • Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37(2):e3377. doi:10.1002/dmrr.3377
  • Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021
  • Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005
  • Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1463–1465. doi:10.1016/j.dsx.2020.07.054
  • Umakanthan S, Bukelo MM, Gajula SS. The Commonwealth Caribbean COVID-19: regions resilient pathway during pandemic. Front Public Health. 2022;10:844333. doi:10.3389/fpubh.2022.844333
  • COVID-19 data repository by the center for systems science and engineering (CSSE) at Johns Hopkins University. Available from: https://github.com/CSSEGISandData/COVID-19. Accessed February 15, 2023.
  • Horita N, Fukumoto T. Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic. J Med Virol. 2023;95(1):e28231. doi:10.1002/jmv.28231
  • Graña C, Ghosn L, Evrenoglou T, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12(12):CD015477. doi:10.1002/14651858.CD015477
  • Umakanthan S, Patil S, Subramaniam N, Sharma R. COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey. Vaccines(Basel). 2021;9(10):1064. doi:10.3390/vaccines9101064
  • Umakanthan S, Lawrence S. Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. Postgrad Med J. 2022;98(1164):756–764. doi:10.1136/postgradmedj-2021-141365
  • Umakanthan S, Bukelo MM, Bukelo MJ, Patil S, Subramaniam N, Sharma R. Social environmental predictors of COVID-19 vaccine hesitancy in India: a population-based survey. Vaccines(Basel). 2022;10(10):1749. doi:10.3390/vaccines10101749
  • Iftimie S, López-Azcona AF, Vicente-Miralles M, et al. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PLoS One. 2020;15(9):e0234452. doi:10.1371/journal.pone.0234452
  • Yamada G, Hayakawa K, Matsunaga N, et al. Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalization. Epidemiol Infect. 2021;149:e175. doi:10.1017/S0950268821001837
  • Dai WC, Zhang HW, Yu J, et al. CT imaging and differential diagnosis of COVID‐19. Can Assoc Radiol J. 2020;71(2):195‐200. doi:10.1177/0846537120913033
  • Chen H, Ai L, Lu H, Li H. Clinical and imaging features of COVID‐19. Radiol Infect Dis. 2020;7(2):43–50. doi:10.1016/j.jrid.2020.04.003
  • Yang W, Sirajuddin A, Zhang X, et al. The role of imaging in 2019 novel coronavirus pneumonia (COVID‐19). Eur Radiol. 2020;30(9):4874–4882. doi:10.1007/s00330-020-06827-4
  • Zheng Y, Wang L, Ben S. Meta-analysis of chest CT features of patients with COVID-19 pneumonia. J Med Virol. 2021;93(1):241–249. doi:10.1002/jmv.26218
  • Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):210–217. doi:10.1148/radiol.2020200274
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Ayanian S, Reyes J, Lynn L, Teufel K. The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort. Biomark Med. 2020;14(12):1091–1097. doi:10.2217/bmm-2020-0309
  • d’Alessandro M, Cameli P, Refini RM, et al. Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19. J Med Virol. 2020;92(10):2216–2220. doi:10.1002/jmv.26087
  • Sugiyama M, Kinoshita N, Ide S, et al. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021;766:145145. doi:10.1016/j.gene.2020.145145
  • Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical Illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020;180(8):1081–1089. doi:10.1001/jamainternmed.2020.2033
  • Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339. doi:10.1136/bmj.m3339
  • Fan G, Tu C, Zhou F, et al. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3):2002113. doi:10.1183/13993003.02113-2020